Testing effectiveness (Phase 2)Active Not RecruitingNCT05798923
What this trial is testing
LAM-001 for the Treatment of Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
Who this might be right for
Pulmonary Hypertension Due to Lung Diseases and Hypoxia
OrphAI Therapeutics 85